Accelerate Diagnostics Announces Emergency Use Authorization for Covid-19 Antibody Test
This new testing platform will speed up health checks by determining whether asymptomatic people have COVID-19 antibodies in 30 minutes.
Accelerate Diagnostics
AXDX
AXDX
$11.50
$0.35
3.1%
Price as of February 24, 2021, 9:00 p.m. EST
View Interactive AXDX Charts
Accelerate Diagnostics, Inc.
Interactive Chart
News & Analysis: Accelerate Diagnostics
Accelerate Diagnostics (AXDX) Q1 2020 Earnings Call Transcript
AXDX earnings call for the period ending March 31, 2020.
Accelerate Diagnostics (AXDX) Q4 2019 Earnings Call Transcript
AXDX earnings call for the period ending December 31, 2019.
2 Growing Healthcare Stocks You Should Know
Two of the sector's biggest winners of the past 10 years are still flying under the radar. Which looks like the better buy today?
The 10 Best Healthcare Stocks of the Decade
Which biotech was a 37-bagger?
Accelerate Diagnostics (AXDX) Q3 2019 Earnings Call Transcript
AXDX earnings call for the period ending September 30, 2019.
Accelerate Diagnostics (AXDX) Q2 2019 Earnings Call Transcript
AXDX earnings call for the period ending June 30, 2019.
Accelerate Diagnostics (AXDX) Q1 2019 Earnings Call Transcript
AXDX earnings call for the period ending March 31, 2019.
Accelerate Diagnostics Corp (AXDX) Q4 2018 Earnings Conference Call Transcript
AXDX earnings call for the period ending December 31, 2018.
Why Accelerate Diagnostics Inc Is Soaring Today
Shares jump after the FDA gives the green light to two of the company's products.
